Mohsen Soltanshahi

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Acute Myeloid Leukemia

Induced Apoptosis

Top Venues

Iranian journal of pharmaceutical research : IJPR

This page only lists publications with an associated author ORCID identifier.

Publications

Abbas Ranjbar, Mohsen Soltanshahi, Saeid Taghiloo, Hossein Asgarian-Omran
Glucose Metabolism in Acute Myeloid Leukemia Cell Line Is Regulated via Combinational PI3K/AKT/mTOR Pathway Inhibitors. Iranian journal of pharmaceutical research : IJPR 22 (1) (2023)
Faezeh Mortazavi, Mohsen Soltanshahi, Gholamhossein Tamaddon
Evaluation of the Relationship Between Serum miR-200b-3p and miR-214-3p Expression Levels with Soluble ACE2 and TMPRSS2 in COVID-19 Patients. Iranian journal of pharmaceutical research : IJPR 22 (1) (2023)
Faezeh Mortazavi, Mohsen Soltanshahi, Gholamhossein Tamaddon
Evaluation of the Relationship Between Serum miR-200b-3p and miR-214-3p Expression Levels with Soluble ACE2 and TMPRSS2 in COVID-19 Patients. Iranian journal of pharmaceutical research : IJPR 22 (1) (2023)
Abbas Ranjbar, Mohsen Soltanshahi, Saeid Taghiloo, Hossein Asgarian-Omran
Glucose Metabolism in Acute Myeloid Leukemia Cell Line Is Regulated via Combinational PI3K/AKT/mTOR Pathway Inhibitors. Iranian journal of pharmaceutical research : IJPR 22 (1) (2023)